Show simple item record

dc.contributor.authorRoman-Canal, Berta
dc.contributor.authorMoiola, Cristian P.
dc.contributor.authorGatius Calderó, Sònia
dc.contributor.authorBonnin, Sarah
dc.contributor.authorRuiz Miró, Maria
dc.contributor.authorGonzález, Esperanza
dc.contributor.authorGonzález-Tallada, Xavier
dc.contributor.authorLlordella, Ivanna
dc.contributor.authorHernández, Isabel
dc.contributor.authorPorcel Pérez, José Manuel
dc.contributor.authorGil-Moreno, Antonio
dc.contributor.authorFalcon-Perez, Juan M.
dc.contributor.authorPonomarenko, Julia
dc.contributor.authorMatias-Guiu, Xavier
dc.contributor.authorColás, Eva
dc.date.accessioned2020-03-05T10:28:10Z
dc.date.available2020-03-05T10:28:10Z
dc.date.issued2019
dc.identifier.issn2072-6694
dc.identifier.urihttp://hdl.handle.net/10459.1/68148
dc.description.abstractEndometrial cancer (EC) is the sixth most common cancer in women worldwide and is responsible for more than 89,000 deaths every year. Mortality is associated with presence of poor prognostic factors at diagnosis, i.e., diagnosis at an advanced stage, with a high grade and/or an aggressive histology. Development of novel approaches that would permit us to improve the clinical management of EC patients is an unmet need. In this study, we investigate a novel approach to identify highly sensitive and specific biomarkers of EC using extracellular vesicles (EVs) isolated from the peritoneal lavage of EC patients. EVs of peritoneal lavages of 25 EC patients were isolated and their miRNA content was compared with miRNAs of EVs isolated from the ascitic fluid of 25 control patients. Expression of the EV-associated miRNAs was measured using the Taqman OpenArray technology that allowed us to detect 371 miRNAs. The analysis showed that 114 miRNAs were significantly dysregulated in EC patients, among which eight miRNAs, miRNA-383-5p, miRNA-10b-5p, miRNA-34c-3p, miRNA-449b-5p, miRNA-34c-5p, miRNA-200b-3p, miRNA-2110, and miRNA-34b-3p, demonstrated a classification performance at area under the receiver operating characteristic curve (AUC) values above 0.9. This finding opens an avenue for the use of EV-associated miRNAs of peritoneal lavages as an untapped source of biomarkers for EC.ca_ES
dc.description.sponsorshipThis research was funded by Generalitat de Catalunya, grant numbers SLT002/16/00274, 2017SGR1661, and 2017SGR1368; by CIBERONC, grant numbers CB16/12/00328 and CB16/12/00231; by Instituto Salud Carlos III, grant number PIE15/00029 and by Asociación Española Contra el Cáncer (AECC), grant number GCTRA1804MATI.ca_ES
dc.language.isoengca_ES
dc.publisherMDPIca_ES
dc.relation.isformatofReproducció del document publicat a https://doi.org/10.3390/cancers11060839ca_ES
dc.relation.ispartofCancers, 2019, vol. 11, núm. 6ca_ES
dc.rightscc-by (c) Roman-Canal et al., 2019ca_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectEndometrial cancerca_ES
dc.subjectUterine cancerca_ES
dc.subjectExosomesca_ES
dc.subjectBiomarkersca_ES
dc.subjectMiRNAsca_ES
dc.titleEV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancerca_ES
dc.typeinfo:eu-repo/semantics/articleca_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_ES
dc.identifier.doihttps://doi.org/10.3390/cancers11060839


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

cc-by (c) Roman-Canal et al., 2019
Except where otherwise noted, this item's license is described as cc-by (c) Roman-Canal et al., 2019